Company Update (NYSE:GE): Leading forensic laboratories participate in independent validation of the GE Healthcare Life Sciences and NetBio Rapid DNA system
May 07, 2014 at 08:23 AM EDT
[Business Wire] – GE Healthcare Life Sciences, , and NetBio named today several of the laboratories participating in the recently announced comprehensive developmental validation of DNAscan™ Rapid DNA Analysis™ System. Read more on . . . → Read More: Company Update (NYSE:GE): Leading forensic laboratories participate in independent validation of the GE Healthcare Life Sciences and NetBio Rapid DNA system Similar Articles: Company Update: General Electric Company (NYSE:GE) – Driving Towards Healthier Play: GE and PGA TOUR Add Portable Ultrasound to Medical Trailers Company Update (NYSE:GE): Innovation Acceleration: GE Selects Louisville for First Micro-factory Market Update (NYSE:GE): GE Names Three to Leadership Positions
